iRegene Therapeutics secures series B+ financing
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
The Ma’anshan site approval covers pastilles, oral liquids, and powders
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Subscribe To Our Newsletter & Stay Updated